Human 17-beta-HSD1/HSD17B1 PharmaGenie ELISA Kit (SBRS0208)

Target 17β-hydroxysteroid dehydrogenase type 1 (HSD17B1) with this quantitative immunoassay from Assay Genie. HSD17B1 catalyzes the NADPH-dependent reduction of estrone to estradiol, making it a key enzyme in estrogen biosynthesis and a frequently studied target in hormone-dependent cancer research, reproductive endocrinology, and steroidogenesis pathway analysis. The reagents are supplied as a complete kit configured for 96 assays, intended to be refrigerated on arrival and reserved for laboratory research use only. Investigators working on aromatase inhibitor response, breast tissue estradiol production, and endocrine disruption screening routinely rely on quantitative HSD17B1 measurement to complement enzyme activity assays and track protein abundance in cell-derived experimental material.